Relevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditions.
Pharmacol Res
; 161: 105092, 2020 11.
Article
in En
| MEDLINE
| ID: mdl-32758634
Key words
Balixafortide (PubChem CID: 138752609); Chemokine; Decursin (PubChem CID: 442126); Doxorubicin (PubChem CID: 31703); Enzalutamide (PubChem CID: 15951529); Glioblastoma; LY2510924 (PubChem CID: 129010506); Mafosfamid (PubChem CID: 104746); Motixafortide (PubChem CID: 91865076); Multiple sclerosis; Myocardial infarction; Olaptesed pegol (PubChem CID: 86278354); Plerixafor (PubChem CID: 65015); Prostate carcinoma; Renal cell carcinoma; Ulocuplumab (PubChem SID: 381127169)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Central Nervous System Diseases
/
Receptors, CXCR4
/
Chemokine CXCL12
/
Receptors, CXCR
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2020
Type:
Article
Affiliation country:
Switzerland